<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35183399</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-4380</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Trends in microbiology</Title><ISOAbbreviation>Trends Microbiol</ISOAbbreviation></Journal><ArticleTitle>Coxsackie B virus.</ArticleTitle><Pagination><StartPage>606</StartPage><EndPage>607</EndPage><MedlinePgn>606-607</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tim.2022.01.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0966-842X(22)00016-6</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marjomäki</LastName><ForeName>Varpu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science, University of Jyväskylä, Jyväskylä, Finland; Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flodström-Tullberg</LastName><ForeName>Malin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. Electronic address: malin.flodstrom-tullberg@ki.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Microbiol</MedlineTA><NlmUniqueID>9310916</NlmUniqueID><ISSNLinking>0966-842X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests M.F.–T. serves on the scientific advisory board of Provention Bio Inc. V.M. has no interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>20</Day><Hour>20</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35183399</ArticleId><ArticleId IdType="doi">10.1016/j.tim.2022.01.016</ArticleId><ArticleId IdType="pii">S0966-842X(22)00016-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>